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Introduction 
This study is designed to investigate if ultraviolet B radiation 
(UVB) found in sunlight causes release of microvesicle particles 
in human skin, and if antioxidants can inhibit their release. 
Microvesicle particles (MVP) are small, 100-1000 namometer-
sized sub-cellular fragments that bud off cell membranes and 
are released into the extracellular environment. Microvesicle 
particles are thought to serve a messenger function within the 
body and be a mediator of systemic response to UVB radiation 
of the epidermis [1]. 
Previous studies have demonstrated that Platelet-activating 
factor (PAF) is produced in human skin upon exposure to UVB 
light, leading to systemic immunosuppression [2,3,4]. 
Furthermore, PAF production in human skin is blocked by 
antioxidants [2,3]. Additional studies show that Microvesicle 
particles are released in human skin upon exposure to UVB 
radiation or PAF. Pretreatment of cell lines with vitamin C or N-
acetyl cysteine block MVP release mediated by UVB, but MVPs 
are still released upon exposure to a PAF agonist. This suggests 
that MVP release from UVB is dependent on a PAF-agonist 
production [5]. 
The previous studies mentioned above were performed on 
either human tissue explants or cell cultures, but not on live 
humans. Therefore, the purpose of this study is to investigate if 
UVB radiation induces MVP formation on human subjects in 
vivo, and if MVP release can be blocked by antioxidants. 
Blocking MVP release would have clinical aspects in potentially 
reducing systemic inflammatory response upon sun exposure 
and reducing severity of sunburns. 
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Methods 
Participants: 8 adult males aged 21-45 with Fitzpatrick type I or 
II skin were enrolled. The procedure is as followed: 
Day 0: 5 x 5 mm area of volar forearm skin exposed to 1000 
J/m2 UVB radiation (about 3-4 hours of direct Summer 
sunlight). After four hours, 5 mm punch biopsies performed on 
irradiated forearm area and control area without UVB 
exposure. MVP were measured from the biopsies using a 
Nanosight instrument. 
Day 1: Subjects begin taking 2000 mg vitamin C and 1000 mg 
vitamin E daily. 
Day 8: The procedure for Day 0 is repeated on the contralateral 
volar forearm and back. 
Fitzpatrick Type I: Pale white skin, always sunburns without tanning 
Fitzpatrick Type II: Fair skin, easily sunburns and poorly tans 
Results 
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* 
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Figure 1: UVB generates MVP in human skin which are blocked by oral 
antioxidant use. Eight male subjects were treated with 1000 J/m2 of UVB 
irradiation to the volar forearm and 5 mm punch biopsies were collected 4 
hours later on both UVB-treated and control (non UVB-treated) skin. This 
procedure was repeated 8 days later on the contralateral volar forearm 
following an 8-day course of daily 2000 mg vitamin C and 1000 mg vitamin E 
antioxidants. The data are Mean +/- SEM. * P<0.05 by Students T test. 
Figure 2: Schematic illustrating release of MVPs upon UVB 







resulting in systemic effects 




This data further supports UVB radiation causing MVP release from 
human keratinocytes in vivo. Administration of antioxidants vitamin 
C and E reduces MVP release. 
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